Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial.

Pui CH, Jeha S, Irwin D, Camitta B

Open source

DOI
10.1038/sj.leu.2402235
Published
2001 Oct
Container
Leukemia
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/sj.leu.2402235,
  title = {Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial.},
  author = {Pui CH and Jeha S and Irwin D and Camitta B},
  year = {2001},
  journal = {Leukemia},
  doi = {10.1038/sj.leu.2402235},
  url = {https://doi.org/10.1038/sj.leu.2402235}
}

RIS

TY  - JOUR
TI  - Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial.
AU  - Pui CH
AU  - Jeha S
AU  - Irwin D
AU  - Camitta B
PY  - 2001
JO  - Leukemia
DO  - 10.1038/sj.leu.2402235
UR  - https://doi.org/10.1038/sj.leu.2402235
ER  - 

APA

CH, P., S, J., D, I., & B, C. (2001). Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial.. Leukemia. https://doi.org/10.1038/sj.leu.2402235

Source records